Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Proteon Thera Com ST (PRTO)

1.325 -0.025 (-1.852%)

8/23/2017  1:37pm

Open:

1.348

Pre. Close:

1.350

High:

1.400

Low:

1.300

Volume:

15,676

Market Cap:

23.35M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.42 - 1.46

1.46 - 1.49

Low:

1.24 - 1.27

1.27 - 1.29

Close:

1.32 - 1.36

1.36 - 1.39

Technical analysis  (as of: 2017-08-23 2:38:41 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.64     One year: 1.91

Support:

Support1: 1.31    Support2: 1.25

Resistance:

Resistance1: 1.40    Resistance2: 1.64

Pivot:

1.32

Moving Averages:

MA(5): 1.33     MA(20): 1.32

MA(100): 1.39     MA(250): 3.92

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 50.00     %D(3): 50.00

RSI:

RSI(14): 49.01

52-Week:

High: 11.450  Low: 1.100  Change(%): -86.1

Average Vol(K):

3-Month: 5719  10-Days 300

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PRTO has closed below upper band by 44.4%. Bollinger Bands are 56.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to PRTO's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 13 Dec 2016 12:54:52 GMT
Proteon Therapeutics' stock plummets after failed trial of kidney disease ...

Tue, 22 Aug 2017 22:41:15 GMT
Flynn James E Maintains 10% Stake in Proteon Therapeutics, Inc. (PRTO)

Wed, 14 Dec 2016 01:07:30 GMT
Despite PATENCY-1 failure, Proteon Therapeutics vows to press on with vonapanitase

Tue, 22 Aug 2017 03:11:15 GMT
Proteon Therapeutics Inc (PRTO) Seeing Increased Action in Session

Mon, 07 Aug 2017 21:00:00 GMT
Proteon Therapeutics Announces Second Quarter 2017 Financial Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

17.62

Shares Float (M)

6.40

% Held by Insiders

41.38

% Held by Institutions

54.90

Shares Short (K)

120

Shares Short Prior Month (K)

156

Stock Financials

EPS

EPS Est. Current Year

-1.510

EPS Est. Next Year

-1.520

EPS Est. Next Quarter

-0.400

Forward EPS

-1.436

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-37.1

Return on Equity (ttm)

-65.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.495

Qtrly Earnings Growth

Operating Cash Flow (M)

-22.95

Levered Free Cash Flow (M)

-13.81

FoxReading.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

P/CF

-1.02

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-02-12

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.